India’s pharma CMO sector a hotbed for private investors

    2020-09-04T11:51:12+00:00September 3rd, 2020|Analysis - India Global Business, India Inc Views - India Global Business|

    Major investments by global private equity giants such as Advent, Carlyle and KKR in India’s contract manufacturing organization sector, amid the pandemic, reflect solid prospects for growth in the country’s complex generics and bulk drug manufacturers.

      India will remain a very attractive place to do business

      2020-03-24T07:45:48+00:00September 25th, 2019|2019, North America Edition – 27th September 2019, UK Edition – 27th September 2019|

      Gaurav Dalmia, Chairman of Dalmia Group Holdings, discusses the current economic and business climate in India while also highlighting some key lessons for Private Equity investors considering the Indian market. How would you classify the Indian investment climate against the backdrop of an economic slowdown? India has been quite a hot destination for investment over the past few years. In the fiscal year 2018-19, India attracted $44 billion in inbound FDI. This is capital that chooses target destinations freely. In [...]